‘Deck chairs on the Titanic’?: AMAG’s CEO departure, drug dumps may not right the ship, analyst says
After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, AMAG’s sudden decision to cut ties with its chief executive could be akin to shifting “deck chairs on the Titanic,” one analyst said. AMAG… Read More »